These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 6373812

  • 1. Gastric inhibitory polypeptide in obesity and diabetes mellitus.
    Service FJ, Rizza RA, Westland RE, Hall LD, Gerich JE, Go VL.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1133-40. PubMed ID: 6373812
    [Abstract] [Full Text] [Related]

  • 2. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
    Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gastric inhibitory polypeptide responses and glucose turnover rates after natural meals in type II diabetic patients.
    Osei K, Falko JM, O'Dorisio TM, Fields PG, Bossetti B.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):325-30. PubMed ID: 3510224
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Gastric inhibitory polypeptide hypersecretion in diabetes mellitus: effect of sulfonylurea treatment.
    Coxe JS, O'Dorisio TM, Cataland S, Crockett SE.
    J Clin Endocrinol Metab; 1981 May; 52(5):1002-5. PubMed ID: 7014585
    [Abstract] [Full Text] [Related]

  • 11. Release of gastric inhibitory polypeptide in totally pancreatectomized patients.
    Miyata M, Izukura M, Hamaji M, Nakao K, Kawashima Y.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1261-4. PubMed ID: 3889032
    [Abstract] [Full Text] [Related]

  • 12. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
    Verdich C, Toubro S, Buemann B, Lysgård Madsen J, Juul Holst J, Astrup A.
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506
    [Abstract] [Full Text] [Related]

  • 13. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M, Grill V, Efendić S.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [Abstract] [Full Text] [Related]

  • 14. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.
    Carr RD, Larsen MO, Jelic K, Lindgren O, Vikman J, Holst JJ, Deacon CF, Ahrén B.
    J Clin Endocrinol Metab; 2010 Feb; 95(2):872-8. PubMed ID: 20008019
    [Abstract] [Full Text] [Related]

  • 15. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study.
    Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ, Ikramuddin S.
    J Surg Res; 2007 Jul; 141(1):31-9. PubMed ID: 17574036
    [Abstract] [Full Text] [Related]

  • 16. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [Abstract] [Full Text] [Related]

  • 17. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
    Gutniak M, Grill V, Wiechel KL, Efendić S.
    Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157
    [Abstract] [Full Text] [Related]

  • 18. Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.
    Ebert R, Creutzfeldt W.
    Acta Diabetol Lat; 1989 Jul; 26(1):1-15. PubMed ID: 2665406
    [Abstract] [Full Text] [Related]

  • 19. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
    Clore JN, Post EP, Bailey DJ, Nestler JE, Blackard WG.
    J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502
    [Abstract] [Full Text] [Related]

  • 20. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
    Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK.
    J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.